CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,579 | -46.4% | 186,410 | -6.1% | 0.02% | -50.0% |
Q2 2023 | $238,166 | +2.5% | 198,472 | -0.1% | 0.05% | -13.2% |
Q1 2023 | $232,399 | +50.1% | 198,632 | +1.4% | 0.05% | +35.9% |
Q4 2022 | $154,797 | -35.5% | 195,946 | -1.2% | 0.04% | -40.9% |
Q3 2022 | $240,000 | +32.6% | 198,405 | +0.8% | 0.07% | +29.4% |
Q2 2022 | $181,000 | -47.8% | 196,867 | +1.6% | 0.05% | -47.4% |
Q1 2022 | $347,000 | +19.2% | 193,715 | +2.6% | 0.10% | +18.3% |
Q4 2021 | $291,000 | +3.6% | 188,796 | +36.6% | 0.08% | -7.9% |
Q3 2021 | $281,000 | -40.5% | 138,213 | +2.0% | 0.09% | -42.2% |
Q2 2021 | $472,000 | +139.6% | 135,508 | +22.3% | 0.15% | +116.9% |
Q1 2021 | $197,000 | – | 110,787 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Inspire Advisors, LLC | 193,715 | $347,000 | 0.10% |
Wealth Advisory Solutions, LLC | 156,850 | $281,000 | 0.06% |
Horst & Graben Wealth Management LLC | 75,722 | $136,000 | 0.03% |
Miller Investment Management, LP | 50,000 | $90,000 | 0.01% |
Cutler Group LLC / CA | 291,300 | $112,000 | 0.01% |
Syverson Strege & Co | 2,145 | $4,000 | 0.00% |
Alberta Investment Management Corp | 172,185 | $308,000 | 0.00% |
HighTower Advisors, LLC | 217,623 | $389,000 | 0.00% |
Kestra Advisory Services, LLC | 40,137 | $72,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 2,272,145 | $4,067,000 | 0.00% |